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In this Review we focus on computational tools and methodologies for analyzing and integrating high-dimensional biomedical data relevant to understanding the organization, function and dynamics of the immune system, and its relevance to disease. We describe how integrative informatics and network biology techniques applied to large data sets can be used to elucidate complex immune-system states (see Box 1 for key terms). We discuss some of the most important challenges facing systems immunology and how computational tools can be applied to immunology to advance our understanding of how various functional molecular circuits interact in the immune system, and lay the groundwork for translating systems immunology data into clinical applications.
Immunological profiling
Two major tasks in immunology are to identify markers (for example, genes or proteins) or the functional characteristics that define various immune cell states or developmental stages and to determine how these components interact in a variety of circumstances. Highthroughput molecular profiling technologies enable diverse strategies for investigating complex immune states.
Genome-wide transcriptional profiling is a systematic, unbiased approach to examine how transcript changes correlate with diverse states of the immune system. Hypothesis-free evaluation of these states by transcriptional profiling can be used to identify relationships that may have been more difficult to identify or even completely missed using more targeted approaches. Transcriptional profiles of immune-system cells have been used to develop molecular signatures for autoimmunity [1] [2] [3] , to explore vaccine efficacy [4] [5] [6] [7] , to distinguish various phases of infection [8] [9] [10] [11] and to suggest new treatment options for patients with rheumatological disease 12 and lymphomas 12, 13 .
Population studies designed to determine the links between genotype and phenotype have uncovered numerous genetic variations that influence function of the immune system 14, 15 . A recent study identified 23 nucleotide variants from 13 genetic loci that regulate frequencies of immune-system cells 16 . To date, genome-wide association studies (GWAS) have linked more than 275 genetic loci with one or more autoimmune diseases 17 . Many of these loci form clusters of risk variants, as their gene products map to common biological pathways and suggest common molecular underpinnings in autoimmunity [18] [19] [20] [21] . Further high-resolution mapping of immune-system genes with high-throughput sequencing is likely to highlight underlying roles for both common and rare immune system-associated genetic variations across a broad number of diseases 2, 22 .
Human leukocyte antigen (HLA) genes are among the most polymorphic in the genome. Given the thousands of allelic variants and the exquisite specificity of antigen recognition, accurate assignment of HLA genotype is required for certain organ or bone marrow transplants. Switching from serological HLA typing to high-resolution HLA typing using high-throughput sequencing platforms has improved the donor-matching process and increased survival outcomes in recipients 23, 24 . Recently, a new sequencing strategy was developed for highthroughput yet high-resolution HLA typing by deep sequencing 25 . This technique is cost-effective, which increases the likelihood of its adoption in a clinical setting, and can be applied to other polymorphic genes. In addition to HLA genotyping for clinical applications, highthroughput sequencing can help (i) identify immunogenetic risk factors for disease 26 , (ii) examine HLA polymorphism across population and pathogenic diversity 27 and (iii) select immunodominant HLA-restricted T cell epitopes (for example, for vaccine or tetramer design 28 ).
DNA sequencing technologies have also been successfully used to monitor the human immune system in multiple contexts including responses of vaccines 29, 30 , evolution of viral variants to escape immune detection 31 , diagnostics for leukemia 32 and profiling of T cell antigen receptor (TCR) 33 or antibody repertoires 34 . A general computational strategy for repertoire analysis involves alignment, clustering and phylogenetic tree construction techniques 29, 35 . This strategy requires robust computational algorithms to handle the massive data sets. One example of such a program is the open-source TCR repertoire analysis software MiTCR, which can efficiently process and analyze TCR sequences from hundreds of millions of raw high-throughput sequencing reads 36 (other programs are listed in Table 1 ). Repertoire analysis relies heavily on having good reference sequences for proper statistical comparisons and diversity estimates. The ImMunoGeneTics (IMGT) information database (http://www. imgt.org/) contains the largest collection of reference sequences for immunoglobulins, TCRs and major histocompatibility complexes (MHCs). This database provides a web portal for researchers to compare up to 450,000 of their measured sequences against a reference to identify germ-line rearrangements, track hypersomatic evolution in response to antigenic challenge and identify specific clones that might be associated with disease 37 . The techniques and technical issues for high-throughput sequencing and their diagnostic applications for medicine are reviewed in ref. 38 .
Functional and integrative genomic analysis
The investigation of genome-wide patterns of mRNA expression in cells of the immune system can identify drivers of the immune-system response to environmental factors (such as antigens, cytokines and small molecules) within and across cells and organisms. Extraction of RNA from cells followed by high-throughput sequencing (RNA-seq) is a powerful method to quantify transcriptomes and identify splice variants 39, 40 . Applied to immune cells, this technology has revealed the transcriptional profiles of primary B cells and monocytes 41 as well as the genetic programming underlying helper T cell development 42 , T H 17 cell lineage entry 43 and dendritic cell maturation after stimulation with lipopolysaccharide 44 . Several software packages exist that perform differential gene expression analysis of RNA-seq data 40, [45] [46] [47] [48] . These packages follow a similar protocol, which includes normalizing the RNA count data, identifying differentially expressed genes and estimating false discovery rates. In addition, the programs Cufflinks and DEXSeq 49 test differential exon expression to examine splice variation, whereas ERANGE 40 analyzes single-nucleotide polymorphisms (SNPs).
Given that transcriptional profiling of microarray or RNA-seq data often yields many differentially expressed genes, enrichment analysis is a common computational approach that helps with the functional interpretation of these gene lists. The popular gene-set enrichment analysis (GSEA) algorithm 50 -as well as extensions of the technique 51 -evaluates ranked gene lists for statistical enrichment of genes involved in defined pathways and cellular processes (for example, cytokine signaling, antigen presentation and inflammatory response). This technique has become a useful tool for immunological discovery with the proliferation of publicly available data 52 . For example, the Molecular Signatures Database (MSigDB 53 ) contains thousands of gene sets (for example, biological pathways and oncogene signatures) gathered from analyses of transcriptional profiling experiments that researchers can use to annotate and interpret results from expression data, including an 'immunological signatures' gene set collection from data provided by the Human Immunology Project Consortium. Two popular packages that implement GSEA include GenePattern 54 and database for annotation, visualization and integrated discovery (DAVID) 55, 56 . A software package called Enricher extends the capabilities of GSEA by offering an interactive application with visualization tools that facilitate collaborative analysis through the web or mobile devices 57 .
One approach for understanding genetic drivers of immune-sytem processes and related diseases is to measure DNA variation and transcriptional profiles from the same sample and then examine the statistical relationships between DNA variation and gene-expression traits. Expression quantitative trait loci (eQTL) analysis is a robust statistical technique that matches variation in a quantitative trait (for example, mRNA expression) to DNA variation at specific genomic loci. eQTL relationships suggest DNA-RNA regulatory interactions. However, genome-wide analysis can require statistical testing of billions of possible eQTL associations (transcript to SNP), which is computationally intensive and necessitates efficient analytical tools. One software package for such analysis, MatrixEQTL 58 (others are listed in Table 1 ), uses efficient mathematical operations in modern computer programs, achieving 2-3 orders of magnitude faster run times over other software tools (for example, a difference between ten minutes and ~3.5 days for a moderately sized data set).
eQTL analysis provides a means to understand immunological processes and prioritize key drivers of disease. System-wide genetic profiling (for example, GWAS) of immune traits often identifies associations with numerous genomic loci. A recent GWAS analysis that looked at the largest collection of patients with inflammatory bowel disease identified more than 70 new loci associated with Crohn's disease or ulcerative colitis 59 . In that study, eQTL associations were used to help prioritize causal genes in loci associated with inflammatory bowel disease. eQTL analysis has also been recently used to identify the downstream regulatory targets of expression-modifying SNPs associated with systemic lupus erythematous and type 1 diabetes 60 . Such integrative analysis highlights the pathways and common connections in complex diseases. Finally, the genotype-tissue expression (GTEx) project is building a massive biospecimen repository to establish tissue-specific eQTL profiles for more than 40 tissues across roughly 1,000 samples 61 . This resource will be an invaluable tool for identifying eQTLs conserved across cell types and tissues, and also for identifying tissue-specific, and eventually cell type-specific, eQTLs that could clarify how SNPs alter expression or binding of specific transcription factors and influence epigenetic regulation.
Cytometry
Single-cell mass cytometry (using the CyTOF mass cytometer) has increased the amount of phenotypic characterization that can be obtained from populations of cells 62 . Currently, ~40 surface markers r e v i e w 1 2 0 VOLUME 15 NUMBER 2 FEBRUARY 2014 nature immunology r e v i e w 68 .
Informatics approaches to integrate molecular data sets Informatics approaches that integrate high-throughput data sets across multiple time points or cell types have been used to map the topological organization of immune-system networks and elucidate the molecular mechanisms that regulate immune function. Chromatin immunoprecipitation followed by high-throughput genomic sequencing (ChIP-seq) was combined with RNA-seq to measure the regulatory programming of transcriptional and epigenetic markers that drive early T cell development 42 . Multiple studies have explored T helper cell lineage differentiation 69 . For example, time-course data from genomewide transcriptional profiling were integrated with publicly available data of transcription-factor binding sites to generate a regulatory network model of T H 17 cell differentiation 43 . This model identified novel control elements and two opposing subnetworks that regulate T H 17 cellular fate. Similarly, ChIP-seq was combined with RNA-seq and transcriptional-profiling (microarray) platforms to construct a predictive regulatory network model for T H 17 cells 70 . Combining these data recovered known T H 17 cell genes and uncovered novel regulatory interactions that control T H 17 cell plasticity 70 . The primary data, resulting networks and analytical tools from this effort are available to the scientific community (http://th17.bio.nyu.edu/). Additionally, methods that integrate gene variants associated with disease in population-based studies, genomic occupancy of transcription factors and genome-wide expression profiling have been used to uncover potential functional links between genetic polymorphisms and phenotypic disease traits. For example, ~800 disease-associated SNPs were linked with NF-κB DNA-binding profiles from ten individuals and Figure 1 Integrating biological data from multiple sources to construct regulatory network models. State-of-the-art computational techniques combine information from largescale public data sets with omics measurements collected from the samples under study to generate multiscale causal models. Whenever possible, samples should be collected from multiple tissues or states in an individual (for example, diseased and healthy) at several time points. Measurements from single tissues miss important context-specific regulatory interactions that are responsible for disease. Single time points (cross-sectional studies) fail to capture the system dynamics and often require larger sample sizes to detect intersample variability. WGS, whole-genome sequencing. Ab, antibody.
or intracellular proteins can be measured simultaneously, providing an unprecedented number of possible parameters to characterize different cell types (for example, 190 to 780 biaxial plots for 20 to 40 markers, respectively). High-throughput cytometric data now require automated strategies to process the high-dimensional information and identify cell types based on the extent of similarity among a specified set of markers. Numerous programs exist for automated cytometry analysis 63 . One software program capable of analyzing mass and flow cytometry data is spanning-tree progression analysis of densitynormalized events (SPADE) 64 . SPADE clusters cells with similar marker intensities and connects clusters into a tree structure, which compresses the multidimensional cytometric data into two dimensions for visualization and enables discovery of new cell subsets and states. This algorithm was applied to reconstruct the hematopoietic lineage and monitor cell phenotype and signaling changes after perturbations with cytokines or small molecules 62 .
Automated approaches should ideally retain the single-cell resolution while using an unbiased, data-driven modality to select the most informative combinations of markers to determine distinct cell types or classify samples while filtering out artifacts 63 . Following this strategy, principal-component analysis was used to identify combinations of cytokines present in different T cell subsets 65 . In that work, subsets were displayed on a two-dimensional plot and color-coded based on antigen specificity, which revealed that viral specificities colocalized to different locations (i.e., differing subsets) in this plot 65 . A nonlinear dimensionality-reduction technique was applied to classify cancerous and noncancerous bone marrow samples, providing a mechanism to identify abnormal cells after treatment as a means to identify minimal residual disease 66 . These computational techniques reduce complexity in visualizing multidimensional data and can highlight differences in cell subsets. Two areas for which there are unmet needs for highthroughput cytometric techniques are (i) computational methods that integrate cytometric data with other genome-wide profiling and (ii) statistical methods for data transformation and hypothesis testing between samples.
Deconvolving cell-specific profiles Ideally, each cell population of interest would be carefully sorted and transcriptionally profiled, but this is not always feasible because of protocol, sample or resource constraints. Computational methods can be used to estimate cell-specific transcriptional profiles from genome-wide expression data measured from heterogeneous samples (for example, whole-blood gene expression values), using measured cell-type proportions such as those obtained from a complete blood 1 2 2 VOLUME 15 NUMBER 2 FEBRUARY 2014 nature immunology r e v i e w mRNA expression profiles to connect variation in regulatory elements and gene expression levels with disease 71 . Such multi-data set integration provides a method to compare transcription-factor binding across individuals and led to the finding that inflammatory disease-associated SNPs are enriched at the NF-κB binding site 71 . Two key challenges for connecting information from genomic variation to allele-specific binding and expression data include constructing a model of a personal diploid genome sequence and then correlating RNA-seq and ChIP-seq data onto the sequence. The software tools AlleleSeq 72 and the ACT 73 (aggregation and correlation toolbox) offer solutions to the challenges of coordinating and comparing genomic, transcriptomic and ChIP-seq data.
Network biology and building global models for immunology
One aim of systems immunology is to construct comprehensive, multiscale network models that accurately capture all of the regulatory elements in the immune system 74, 75 . Network models can be generated by a number of different methods, but they all have similar features. These mathematical models represent maps for potential connections among intracellular and intercellular components, suggesting new functional roles for specific genes, proteins or metabolites (Fig. 1) . For immunologists already focused on a particular molecule of interest, networks will potentially place the molecule in the context of new pathways, molecular interactions and/or even an unanticipated tissue or disease link, potentially leading to specific hypotheses to be tested in experimental models. The procedure for constructing a network uses statistical techniques to estimate the most likely relationships between molecular entities (for example, transcription factors and noncoding RNAs and mRNAs) 76 . After a preliminary network model is constructed, predicted connections are perturbed to test and validate the model through in vitro assays 77 . Applications of network modeling to immunology have uncovered several known mechanisms and identified new mechanisms in regulation of immune system cells. Network modeling has provided high-resolution maps of the regulatory circuitry that control differentiation of hematopoietic cell lineage 78 , differentiation of T H 17 cells 43 and the transcriptional regulators for 249 cell types of the mouse immune system 79 . Furthermore, viral-sensing transcriptional networks in dendritic cells have been constructed for pathogen recognition through signaling of Toll-like receptors 80, 81 .
Weighted gene coexpression network analysis can depict the system-wide influence of mRNA expression as well. Constructing this type of network requires soft thresholding of correlations in defining connections between two nodes 82 . This analysis can provide data-defined groups of genes (modules) that offer a new modality for biological interpretability 59, [83] [84] [85] . Coexpression network analysis determines modules by organizing genes that correlate more with one another than with other sets of genes across individual samples within an analysis group. Coexpression network analysis can also be used as a framework to evaluate a common denominator in a meta-analysis of patient studies or even cross-species disease models 86 . Likewise, differential connectivity can be used to analyze altered correlation in comparing two coexpression networks from different groups (for example, healthy versus disease) 84 .
Probabilistic causal networks are becoming increasingly more prevalent in modeling the immune system. This computational technique integrates genomic variation (for example, genome-wide SNPs) with quantitative expression levels of mRNA (for example, transcriptional profiling of patient tissues) to infer causal directionality of correlated genes in the networks 87 . Causal regulatory networks are constructed r e v i e w using conditional correlations inherent in eQTLs. 'Priors' such as data collected about known protein-protein interactions, transcriptionfactor binding sites and other molecular relationships can also aid in inference of causality from correlation. Normal genetic variation observed in a population offers a natural perturbation to the immune system from which to construct predictive network models for human disease. Bayesian methods are used to infer causal relationships between molecular interactions by randomly generating many possible network models and using statistical techniques to select a consensus model that best fits the data. A causal regulatory network constructed from multiple tissue samples from 1,000 obese patients undergoing gastric bypass surgery was previously described 88 . The resulting network model identified a macrophage-biased metabolic network enriched for genes associated with a number of other autoimmune diseases. This computational approach has been applied to data collected from multiple tissue types. The analyses have revealed a number of new genetic associations for type 2 diabetes 89 , identified key drivers in inflammatory disease 86 and uncovered a new gene (TYROBP) associated with Alzheimer's disease 84 .
To explore how an immunological network can bridge therapeutic targets with disease pathophysiology, we selected more than 6,800 drugs (US Food and Drug Administration-approved small molecules and biologics as well as experimental compounds) curated from DrugBank 90 and display connections where specific and/or nonspecific drug targets converge with genes featured in the network. In addition, we mapped diseases from GWAS to their respective genes on the network (Fig. 2) . To refine the drug to immune system-related genes to disease axis, we selected connections between drugs and diseases that were mediated through a common gene or two (Fig. 2a) . Although the network is at molecular resolution such that single drugs map to individual genes and distinct diseases, we aggregated drugs, genes and diseases into higher-level categories based on anatomical therapeutic chemical classification, Gene Ontology enrichment terms and disease group, respectively (Fig. 2b) .
This approach illustrates how genes in an immunological network connect diverse diseases and provides a window into potential therapeutic targets for using existing drugs to potentially treat diseases both related and unrelated to the immune system. A detailed map of the interactions between drug targets and what immune-system cell types are most likely to express these targets remains largely unexplored and thus offers opportunities for improved understanding through computational approaches. One such opportunity is to leverage transcriptional profiles from cells perturbed with small molecules in vitro to repurpose drugs as more effective therapeutics for immune system-mediated diseases 91 . Using this approach, the antiseizure drug topiramate was shown to be a potential candidate for the treatment of inflammatory bowel disease 92 . A further step is to integrate this computational framework with network modeling as a general strategy for personalized medicine, as the ability to sequence a tumor cell's genome may suggest alternative drugs or immune system-targeted therapy tailored specifically to an individual (Fig. 3) .
Representing immune network models Software packages that read network models and display the web of connections in an interactive mode are essential tools for augmenting analysis, integrating additional biological or clinical information in a network and interpreting the myriad nonlinear relationships between data sets. The most common computational tool for visualizing and analyzing molecular network data is Cytoscape 93 . Cytoscape is an open-source platform, which means anyone can develop computational tools to work within the Cytoscape framework 94 . Hundreds of software tools have been developed to enhance the features and interoperability of Cytoscape, and more packages are continuously being added. For example, PanGIA is a tool for integrating physical and genetic interaction data into hierarchical maps to infer functional relationships between data sets 95 . Software to enhance the features and operability of Cytoscape are in the hundreds, and more are in development.
Human immunology and public repositories
Although mathematical models of the immune system will require further development and computing power to appreciably mimic the dynamics happening in vivo, recent systems approaches have shown great progress [3] [4] [5] [6] [7] [8] . The Human Immunology Project Consortium (HIPC; http://www.immuneprofiling.org/) is a large-scale initiative 
Box 2 Suggestions for analyzing high-dimensional data
Below are some 'rules of thumb' for computational analysis of data generated by high-throughput technologies.
The examples provided suggest one computational tool, but in many cases, a number of alternatives exist (see Table 1 ).
Genetic variation
Evaluate allele frequency spectra in the context of population structure and local ancestry using tools such as Structure (http:// pritchardlab.stanford.edu/structure.html) and PCAdmix (https://sites.google.com/site/pcadmix/home/). Evaluate loci and alleles for evolutionary expectations of functional importance using tools such as myPEG (http://www.megasoftware.net/myPEG/myPEG.php).
Use a resource like GWASdb (http://jjwanglab.org/gwasdb/) to map known genotype-phenotype associations. Use HaploReg (http://www.
broadinstitute.org/mammals/haploreg/haploreg.php) or RegulomeDB (http://regulomedb.org/) to integrate with functional genomics data sets (for example, encyclopedia of DNA elements (ENCODE) and eQTL reference databases) to understand how genetic variation might lead to functional differences in expression or regulation. Explore gene-set or pathway enrichment in genomic loci using GRAIL (gene relationships across implicated loci; http://www.broadinstitute.org/mpg/grail/). Look for genetic variation in druggable targets using the drug-gene interaction database (http://dgidb.genome.wustl.edu/).
Transcriptomics
If starting with RNA-seq, process the data with TopHat (http://tophat.cbcb.umd.edu) and Bowtie (http://bowtie-bio.sourceforge.net). Use cufflinks tools to call differential expression and to call variants from RNA reads. If the study sample size is more than 30, consider building gene coexpression networks using an R package for weighted-correlation network analysis (WGCNA).
If the same study incorporates genetic variation data or genetic variants are called from RNA-seq reads, then compute eQTL associations using MatrixEQTL. If the study sample size is >200, consider constructing Bayesian networks using the software package for reconstructing integrative molecular Bayesian networks (RIMBANet Omics. Collection of all the parts (e.g., genes, proteins, metabolites) and their interactions.
r e v i e w this resource (https://immport.niaid.nih.gov/). As additional methods and data sets become available, more researchers will be able to leverage these resources to address specific hypotheses or construct new models that will improve our understanding of immunological processes and ultimately suggest better strategies for addressing the biggest challenges facing clinical and basic immunology.
Challenges for the future Two major challenges for immune monitoring are to determine baseline immunological states from molecular profiles, despite inherent heterogeneity both over time within an individual and across populations, and to associate these molecular states with clinical outcomes or disease. Progress on these issues was made through the integration of multiple data sources collected in medium-sized cohorts (http://www. immuneprofiling.org/). However, bigger sample sizes from diverse demographics are needed to define normal ranges and corresponding deviations that result in clinically meaningful conclusions. Largescale consortia offer one mechanism for building up sample sizes, and leveraging public data can provide another such mechanism.
There is a need for tools that do not require specialized training to allow investigators to build and explore integrated network models. Although advances in computing algorithms and infrastructure offer a range of solutions for analyzing large-scale data sets [96] [97] [98] , the computational models constructed by biomedical engineers require proficiency in computer programming, which often precludes the intended end users, such as biologists and clinicians, from using and integrating these technologies with scientific and clinical practice. To address this problem, we need interactive software solutions that allow researchers to access information in computational models at appropriate levels of detail. An unresolved issue is how to visualize and mine highdimensional data in ways that help determine how complex systems operate. When examining 'omics' data, researchers routinely suffer from 'data fatigue' . Visualization tools are needed that can display data through multiple perspectives, which could then be cycled through rapidly and intuitively 99 . Tools such as Iris 100 and Cytoscape (others are listed in Table 1 ) are important steps toward satisfying these needs.
In this process, the key is to annotate networks with specific pathway or cell-type associations and with a possibility to move to alternative scale network views (for example, proteomics) seamlessly. A tool that enables clicking on genes of interest for synthesis of related literature and other forms of regulation (for example, epigenetic or miRNA-mediated) would be useful, as would flexible network models that synthesize data from parent models and represent molecular interactions present in phenotypic or clinical data clusters sourced from medical records, histologic data and magnetic resonance images or other clinical images.
High-throughput technologies such as high-throughput sequencing and mass cytometry are enabling the generation of massive amounts of data, which require computational tools to process, analyze and visualize. Some suggestions for how to use existing tools to support immunological discovery are provided in Box 2. Accurate and comprehensive mathematical models of complex immune system dynamics can be enhanced through computational approaches that integrate multiple layers of profiling data. Building more complete and predictive models of drug-immune system interactions will be useful for enabling more safe and effective drug discovery and development. Network models and analytics will provide the foundation for understanding how to modulate the immune system and develop diagnostic and prognostic indicators for disease. Immunologists and clinicians are now working with systems biologists to take advantage of numerous computational tools to generate and analyze predictive models of immune function, which can be applied to improve biological understanding of the immune system and provide more effective patient care.
